130 related articles for article (PubMed ID: 9781434)
1. Preoperative predictors for organ-confined disease in Japanese patients with stage T1c prostate cancer.
Ogawa O; Egawa S; Arai Y; Tobisu K; Yoshida O; Kato T
Int J Urol; 1998 Sep; 5(5):454-8. PubMed ID: 9781434
[TBL] [Abstract][Full Text] [Related]
2. Preoperative parameters to predict tumor volume in Japanese patients with nonpalpable prostate cancer.
Furuya Y; Fuse H; Nagakawa O; Masai M
Int J Clin Oncol; 2002 Apr; 7(2):109-13. PubMed ID: 12018107
[TBL] [Abstract][Full Text] [Related]
3. The percent of cores positive for cancer in prostate needle biopsy specimens is strongly predictive of tumor stage and volume at radical prostatectomy.
Sebo TJ; Bock BJ; Cheville JC; Lohse C; Wollan P; Zincke H
J Urol; 2000 Jan; 163(1):174-8. PubMed ID: 10604340
[TBL] [Abstract][Full Text] [Related]
4. Prognostic significance of prostate-specific antigen in stage T1c prostate cancer treated by radical prostatectomy.
Cookson MS; Fleshner NE; Soloway SM; Fair WR
Urology; 1997 Jun; 49(6):887-93. PubMed ID: 9187696
[TBL] [Abstract][Full Text] [Related]
5. Prospective evaluation of men with stage T1C adenocarcinoma of the prostate.
Carter HB; Sauvageot J; Walsh PC; Epstein JI
J Urol; 1997 Jun; 157(6):2206-9. PubMed ID: 9146616
[TBL] [Abstract][Full Text] [Related]
6. Radical prostatectomy for impalpable prostate cancer: the Johns Hopkins experience with tumors found on transurethral resection (stages T1A and T1B) and on needle biopsy (stage T1C).
Epstein JI; Walsh PC; Brendler CB
J Urol; 1994 Nov; 152(5 Pt 2):1721-9. PubMed ID: 7523719
[TBL] [Abstract][Full Text] [Related]
7. Relationship between systematic biopsies and histological features of 222 radical prostatectomy specimens: lack of prediction of tumor significance for men with nonpalpable prostate cancer.
Noguchi M; Stamey TA; McNeal JE; Yemoto CM
J Urol; 2001 Jul; 166(1):104-9; discussion 109-10. PubMed ID: 11435833
[TBL] [Abstract][Full Text] [Related]
8. Comparison of percentage of total prostate needle biopsy tissue with cancer to percentage of cores with cancer for predicting PSA recurrence after radical prostatectomy: results from the SEARCH database.
Freedland SJ; Aronson WJ; Csathy GS; Kane CJ; Amling CL; Presti JC; Dorey F; Terris MK;
Urology; 2003 Apr; 61(4):742-7. PubMed ID: 12670558
[TBL] [Abstract][Full Text] [Related]
9. Improved clinical staging system combining biopsy laterality and TNM stage for men with T1c and T2 prostate cancer: results from the SEARCH database.
Freedland SJ; Presti JC; Terris MK; Kane CJ; Aronson WJ; Dorey F; Amling CL;
J Urol; 2003 Jun; 169(6):2129-35. PubMed ID: 12771734
[TBL] [Abstract][Full Text] [Related]
10. Prediction of pathological stage in patients with clinical stage T1c prostate cancer: the new challenge.
Veltri RW; Miller MC; Mangold LA; O'Dowd GJ; Epstein JI; Partin AW
J Urol; 2002 Jul; 168(1):100-4. PubMed ID: 12050500
[TBL] [Abstract][Full Text] [Related]
11. Pathologic and clinical findings to predict tumor extent of nonpalpable (stage T1c) prostate cancer.
Epstein JI; Walsh PC; Carmichael M; Brendler CB
JAMA; 1994 Feb; 271(5):368-74. PubMed ID: 7506797
[TBL] [Abstract][Full Text] [Related]
12. Preoperative serum prostate specific antigen does not reflect biochemical failure rates after radical prostatectomy in men with large volume cancers.
Noguchi M; Stamey TA; McNeal JE; Yemoto CM
J Urol; 2000 Nov; 164(5):1596-600. PubMed ID: 11025712
[TBL] [Abstract][Full Text] [Related]
13. Clinical significance of nonpalpable prostate cancer with favorable biopsy features in Japanese men.
Kakehi Y; Kamoto T; Ogawa O; Kato T; Tobisu K; Akakura K; Egawa S; Usami M; Maeda O; Arai Y; Sumiyoshi Y; Kamiryo Y; Yoshida O
Eur Urol; 2000 May; 37(5):552-8. PubMed ID: 10765093
[TBL] [Abstract][Full Text] [Related]
14. Ability of sextant biopsies to predict radical prostatectomy stage.
Wills ML; Sauvageot J; Partin AW; Gurganus R; Epstein JI
Urology; 1998 May; 51(5):759-64. PubMed ID: 9610589
[TBL] [Abstract][Full Text] [Related]
15. Complexed prostate-specific antigen as a staging tool for prostate cancer: a prospective study in 420 men.
Sokoll LJ; Mangold LA; Partin AW; Epstein JI; Bruzek DJ; Dunn W; Mohr P; Wallerson G; Chan DW
Urology; 2002 Oct; 60(4 Suppl 1):18-23. PubMed ID: 12384158
[TBL] [Abstract][Full Text] [Related]
16. Preoperative prediction of extracapsular tumor extension at radical retropubic prostatectomy in Taiwanese patients with T1c prostate cancer.
Ou YC; Chen JT; Yang CR; Cheng CL; Ho HC; Kao YL; Ko JL; Hsieh YS
Jpn J Clin Oncol; 2002 May; 32(5):172-6. PubMed ID: 12110644
[TBL] [Abstract][Full Text] [Related]
17. [Preoperative parameters, including percent of positive biopsy cores, in predicting pathological findings after radical prostatectomy].
Inagaki T; Kohjimoto Y; Hagino K; Kuramoto T; Mori T; Kikkawa K; Iba A; Uekado Y; Shinka T
Nihon Hinyokika Gakkai Zasshi; 2007 Mar; 98(3):565-72. PubMed ID: 17419367
[TBL] [Abstract][Full Text] [Related]
18. Are prostate carcinoma clinical stages T1c and T2 similar?
Billis A; Magna LA; Watanabe IC; Costa MV; Telles GH; Ferreira U
Int Braz J Urol; 2006; 32(2):165-71. PubMed ID: 16650293
[TBL] [Abstract][Full Text] [Related]
19. Percent of prostate needle biopsy cores with cancer is significant independent predictor of prostate specific antigen recurrence following radical prostatectomy: results from SEARCH database.
Freedland SJ; Aronson WJ; Terris MK; Kane CJ; Amling CL; Dorey F; Presti JC;
J Urol; 2003 Jun; 169(6):2136-41. PubMed ID: 12771735
[TBL] [Abstract][Full Text] [Related]
20. Nonpalpable stage T1c prostate cancer: prediction of insignificant disease using free/total prostate specific antigen levels and needle biopsy findings.
Epstein JI; Chan DW; Sokoll LJ; Walsh PC; Cox JL; Rittenhouse H; Wolfert R; Carter HB
J Urol; 1998 Dec; 160(6 Pt 2):2407-11. PubMed ID: 9817393
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
